JP2015529462A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529462A5
JP2015529462A5 JP2015530066A JP2015530066A JP2015529462A5 JP 2015529462 A5 JP2015529462 A5 JP 2015529462A5 JP 2015530066 A JP2015530066 A JP 2015530066A JP 2015530066 A JP2015530066 A JP 2015530066A JP 2015529462 A5 JP2015529462 A5 JP 2015529462A5
Authority
JP
Japan
Prior art keywords
pressure
bar
high pressure
microorganisms
inactivation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530066A
Other languages
English (en)
Japanese (ja)
Other versions
JP6438396B2 (ja
JP2015529462A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/057426 external-priority patent/WO2014036345A2/en
Publication of JP2015529462A publication Critical patent/JP2015529462A/ja
Publication of JP2015529462A5 publication Critical patent/JP2015529462A5/ja
Application granted granted Critical
Publication of JP6438396B2 publication Critical patent/JP6438396B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530066A 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法 Active JP6438396B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261694968P 2012-08-30 2012-08-30
US61/694,968 2012-08-30
US201361830425P 2013-06-03 2013-06-03
US61/830,425 2013-06-03
PCT/US2013/057426 WO2014036345A2 (en) 2012-08-30 2013-08-30 Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Publications (3)

Publication Number Publication Date
JP2015529462A JP2015529462A (ja) 2015-10-08
JP2015529462A5 true JP2015529462A5 (OSRAM) 2016-09-15
JP6438396B2 JP6438396B2 (ja) 2018-12-12

Family

ID=49162270

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015530066A Active JP6438396B2 (ja) 2012-08-30 2013-08-30 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法
JP2015530070A Expired - Fee Related JP6405308B2 (ja) 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015530070A Expired - Fee Related JP6405308B2 (ja) 2012-08-30 2013-08-30 キメラksacタンパク質の発現及び高圧により可溶性タンパク質を製造する方法

Country Status (18)

Country Link
US (3) US9169302B2 (OSRAM)
EP (2) EP2890392B1 (OSRAM)
JP (2) JP6438396B2 (OSRAM)
KR (1) KR102208844B1 (OSRAM)
CN (3) CN104717976A (OSRAM)
AP (1) AP2015008331A0 (OSRAM)
AU (4) AU2013308627B2 (OSRAM)
BR (1) BR112015004463B8 (OSRAM)
CA (2) CA2883296A1 (OSRAM)
EA (1) EA031988B1 (OSRAM)
ES (1) ES2744709T3 (OSRAM)
HK (1) HK1211874A1 (OSRAM)
MD (1) MD4608C1 (OSRAM)
MX (3) MX381717B (OSRAM)
NZ (3) NZ705790A (OSRAM)
PH (1) PH12015500700B1 (OSRAM)
RU (1) RU2647568C2 (OSRAM)
WO (2) WO2014036345A2 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968749B2 (en) * 2006-07-21 2015-03-03 Universidade Federal De Minas Gerais—Ufmg Vaccine composition and immunization method
ZA201501696B (en) 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
AU2013308627B2 (en) 2012-08-30 2016-10-27 Boehringer Ingelheim Animal Health USA Inc. Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
BR112015024860B1 (pt) 2013-03-28 2023-11-07 Access To Advanced Health Institute Polipeptídeo de fusão, polinucleotídeo isolado, composição compreendendo dito polipeptídeo, uso da dita composição para estimular uma resposta imune contra leishmania e método in vitro e kit de diagnóstico para detectar infecção por leishmania em uma amostra biológica
CN104758944B (zh) 2015-04-02 2017-11-28 中国科学院过程工程研究所 一种疫苗制剂及其制备方法和用途
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
JP2020152644A (ja) * 2019-03-18 2020-09-24 国立大学法人愛媛大学 Vnarのリフォールディング方法およびvnarの製造方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112120012B (zh) * 2020-09-30 2022-03-22 广东康盾创新产业集团股份公司 一种car-t细胞冻存方法
BR102021000794A2 (pt) * 2021-01-15 2022-07-26 Fundação Oswaldo Cruz Proteína quimérica, kit, método para diagnóstico de leishmaniose, uso de uma proteína quimérica, composição vacinal contra leishmaniose visceral, e, uso de uma composição vacinal

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138854B1 (en) 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Antigenically active amino acid sequences
JP2743177B2 (ja) * 1987-04-24 1998-04-22 財団法人阪大微生物病研究会 百日咳菌の培養方法、及び百日咳トキソイドとその混合ワクチン
JP4111403B2 (ja) 1996-10-11 2008-07-02 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 免疫刺激ポリヌクレオチド/免疫調節分子複合体
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
WO2000002901A1 (en) 1998-07-09 2000-01-20 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
WO2000072703A1 (en) 1999-05-28 2000-12-07 UNIVERSITé LAVAL Inactivation of food spoilage and pathogenic microorganisms by dynamic high pressure
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
KR100863630B1 (ko) 1999-09-25 2008-10-15 유니버시티 오브 아이오와 리써치 파운데이션 면역자극성 핵산
US7615617B2 (en) 1999-10-25 2009-11-10 University Of Delaware Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding
WO2002056824A2 (en) 2000-08-10 2002-07-25 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
US6635223B2 (en) * 2000-10-25 2003-10-21 Andreas Maerz Method for inactivating micro-organisms using high pressure processing
DK1434789T3 (da) * 2000-10-31 2008-07-07 Barofold Inc Forbedret proteindisaggregering og refoldning under tryk
WO2004024027A2 (en) 2002-06-07 2004-03-25 University Of Florida Endodontic files made using bulk metallic glasses
SE525457C2 (sv) 2002-06-24 2005-02-22 Flow Holdings Sagl Förfarande för åstadkommande av en tryckändring mellan två trycktillstånd, högtryckspressanordning samt användning av förfarande eller högtryckspressanordning
AU2004287284B2 (en) * 2003-11-05 2009-11-12 C.B.F. Leti, S.L. Unipersonal Use of specific histones for the treatment of parasitic diseases
US7993580B2 (en) 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
WO2007062174A2 (en) 2005-11-21 2007-05-31 Barofold, Inc. Devices and methods for high-pressure refolding of proteins
CN200945252Y (zh) * 2006-09-01 2007-09-12 天津市华泰森淼生物工程技术有限公司 手动开启式小型超高压生物处理设备
WO2008033556A2 (en) * 2006-09-15 2008-03-20 Barofold, Inc. High pressure treatment of proteins for reduced immunogenicity
WO2008124134A2 (en) 2007-04-05 2008-10-16 Barofold, Inc. High-pressure refolding of proteins in the presence of binding partners
US7829681B2 (en) * 2007-04-05 2010-11-09 Barofold Inc. High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins
EP2207890A4 (en) 2007-10-05 2010-12-15 Barofold Inc HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
RU2440137C1 (ru) * 2007-12-21 2012-01-20 Пфайзер Инк. Термообработанные бактерины и эмульсионные вакцины, полученные из таких термообработанных бактеринов
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
US8603808B2 (en) 2008-05-08 2013-12-10 Merial Limited Leishmania vaccine using sand fly salivary immunogen
US8410258B2 (en) * 2008-05-21 2013-04-02 Infections Disease Research Institute Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
AR073170A1 (es) 2008-05-21 2010-10-20 Infectious Disease Res Inst Vacunas de poliproteinas recombinantes para el tratamiento y diagnostico de leishmaniasis
US20100112660A1 (en) 2008-05-30 2010-05-06 Barofold, Inc. Method for Derivatization of Proteins Using Hydrostatic Pressure
US20110070219A1 (en) 2009-04-27 2011-03-24 Seefeldt Matthew B High pressure protein crystallization
US20120304872A1 (en) * 2010-02-01 2012-12-06 Avure Technologies Ab High-pressure arrangement with locking element preventing rotation of load basket
CN201781934U (zh) * 2010-04-14 2011-04-06 中国农业大学 一种小型框架自动式超高压设备
EP2600843B9 (en) 2010-07-19 2020-03-11 Pressure BioSciences, Inc. Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
AU2013308627B2 (en) * 2012-08-30 2016-10-27 Boehringer Ingelheim Animal Health USA Inc. Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
ZA201501696B (en) * 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Similar Documents

Publication Publication Date Title
JP2015529462A5 (OSRAM)
Sanders et al. Inactivated viral vaccines
JP6438396B2 (ja) 不活化ワクチンを作製するための、ならびに組換えタンパク質をリフォールディング/可溶化させるための高圧デバイスおよび方法
MX2009006755A (es) Celulas y metodologia para generar virus de rna de cadena de sentido negativo no segmentada.
WO2010148511A8 (en) Chimeric influenza virus-like particles comprising hemagglutinin
JPH07505071A (ja) ウイルスの不活性化方法
PH12023551306A1 (en) Protein-based nanoparticle vaccine for metapneumovirus
NO20062044L (no) Piscirickettsia salmonis-antigener og anvendelse derav
CN103792259B (zh) 一种用于评估穿心莲抗菌活性的方法
MX2020006476A (es) Vacuna contra el virus de lassa.
Abdulaziz et al. Evaluation of the Immuno-Responses to Brucella Melitensis.
Greenfield et al. Preparing protein antigens from sodium dodecyl sulfate-polyacrylamide gels for immunization
US10080791B2 (en) Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
CN105854039A (zh) 对液体生物制品中病原体的超高压灭活方法及设备
CN109090421A (zh) 一种空心胶囊臭氧灭菌方法
Silva et al. Pressure-inactivated virus: a promising alternative for vaccine production
Davies et al. Concept and scope of modern vaccines
WO2015120378A8 (en) Porcine epidemic diarrhea virus (pedv) proteins and antigens
JP2004285019A (ja) 生体外異物の不活化方法
Morse Development of a Psoralen+ UVA Light-Inactivated Whole Cell Vaccine for Urinary Tract Infection Caused by Uropathogenic E. coli (UPEC)
He et al. Buccal microneedle-delivered ferritin nanovaccines induce strong respiratory immunity against Pseudomonas aeruginosa
Hamilton et al. The use of negative stain electron microscopy for the examination of pharmaceutical preparations
CN205458909U (zh) 一种淋巴结取物钳
WO2005034841A3 (en) Anthrax vaccine
Pichichero et al. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan